Shares of OneMedNet Corporation (NASDAQ:ONMD) surged 90% in Friday trading following the announcement of its next commercial launch phase. The company is advancing its Real-World Data (RWD) Platform, which is powered by Palantir Foundry.
Following successful demonstrations at major tradeshows on November 10, 2025, OneMedNet is now converting customer evaluations into commercial subscriptions. The company reports it is securing multi-year subscription deals, which represent millions in incremental recurring revenue. This growing adoption spans the life sciences and AI health sectors.
The platform offers access to multimodal datasets from over 2,130 healthcare sites. Customer feedback gathered since Fall 2025 has highlighted the platform’s analytical depth across integrated clinical and longitudinal datasets. Users also noted accelerated cohort feasibility and faster onboarding for data partners.
OneMedNet’s iRWD network provides continuously connected datasets with over two decades of historical depth and access extending three years forward. The platform merges AI-driven search capabilities with real-time data feeds to enhance evidence generation.
“Customer feedback has reinforced the platform’s performance, speed, and depth of discovery,” stated Aaron Green, CEO & President of OneMedNet. “We believe this traction validates our strategy of combining conversational AI-driven search with scalable, prospective data feeds, strengthening customer confidence as we expand subscriptions and deliver fast, intuitive value for Real-World evidence generation.”
OneMedNet specializes in providing regulatory-grade, AI-ready Real-World Data to life sciences and healthcare organizations. This commercial launch significantly advances the company’s recurring revenue model through its focus on multi-year subscription contracts.
For more information on OneMedNet please visit www.onemednet.com .
The post OneMedNet Stock Soars 90% Following Real-World Data Platform Launch appeared first on PRISM MarketView.